Skip to main content
OpenTrials
Recruiting

NCT Number: NCT07073963

Virtual Patient Groups for Sarcoidosis Associated Fatigue

This research study is testing whether Mindfulness-Based Stress Reduction (MBSR) can help reduce fatigue in people with sarcoidosis. The study will also look at whether MBSR can improve symptoms of anxiety and depression.

Participants will be placed into one of two groups:

* One group will take part in an 8-week virtual MBSR program, attend weekly online sessions, keep a daily mindfulness journal, and complete surveys about fatigue, anxiety, and depression. * The other group will join a virtual support group once a month for 5 months and complete the same surveys.

The goal is to see which approach is more helpful for improving fatigue and mental well-being in people with sarcoidosis.

Recruiting

Interested in participating?

Request Info

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

About this study

Fatigue is a common and debilitating symptom of sarcoidosis. There are currently no approved treatments for sarcoidosis associated fatigue. We are testing an MBSR intervention based on previous work showing improvement of sarcoidosis associated fatigue with mindfulness interventions.

Participants will be adults diagnosed with sarcoidosis per self report and experiencing significant fatigue (Fatigue Assessment Scale [FAS] score ≥22). Participants will be recruited through Cleveland Clinic and partnering sarcoidosis clinics. Recruitment includes both in-person and virtual strategies using electronic health record (EHR) screening, MyChart messages, clinician referrals, and self-referral through a recruitment letter. Interested patients will complete eligibility screening, including a virtual or in-person consent process and FAS assessment.

Following enrollment, participants will be randomized 1:1 to either the MBSR intervention or control group (support group). The MBSR intervention consists of 8 weekly, virtual group sessions led by trained facilitators and includes guided mindfulness practices, group discussions, and home practice assignments. The control group will participate in an existing monthly virtual sarcoidosis support group, which includes a brief educational presentation and group discussion.

Study outcomes will be collected using online surveys at three timepoints: baseline (prior to intervention), 8 weeks (immediately post-MBSR), and 5 months (3-month follow-up). Outcomes include fatigue (primary), quality of life, depression, and anxiety. Qualitative interviews will be conducted after the intervention to explore participant experiences with the intervention.

The investigators will conduct an interim analysis to determine feasibility of study for study participants. If there is greater than 30% drop out and drop out assessed by primary investigator, blinded to study results, is determined to be due to intervention components, the study will be paused, the intervention tailored prior to continued recruitment.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Self reported diagnosis of sarcoidosis
  • Fatigue defined as FAS score ≥ 22
  • Age ≥ 18 years old
  • Ability to speak and read English
  • Access to internet
  • Capacity to consent

Exclusion criteria

  • Current daily meditation practice
  • Prior history of engaging in formal mindfulness-based interventions including: MBSR, MBCT, Acceptance and Commitment therapy, Dialectical Behavior Therapy
  • Any condition that would prevent being a suitable candidate for the group intervention (as determined by screening interview) including suicidal ideation.
  • Lack of access to any form of online video access

Treatment and study plan

Virtual Mindfulness Based Stress Reduction Group

Behavioral

Mindfulness Based Stress Reduction is an evidence-based, manualized 8-week group program designed to improve coping with chronic physical and psychological symptoms. MBSR emphasizes mindfulness meditation, body awareness, and gentle movement to cultivate nonjudgmental awareness of present-moment experiences and reduce stress reactivity. The intervention will be delivered in a virtual group setting.

Virtual sarcoidosis support group

Behavioral

Participants attend a once-monthly, virtual support group via secure video conferencing. Each session includes a brief didactic presentation on topics relevant to living with chronic illness (e.g., symptom management, coping strategies, navigating healthcare) followed by a facilitated group discussion. The discussion emphasizes peer support, shared experiences, and emotional processing in a safe, respectful environment. Groups are led by an experienced facilitator with experience in chronic illness care. No home practice is required.

Primary outcomes

  1. PROMIS Fatigue 8a

    Time frame: From enrollment to the end of the study period at 5 months

    validated 8 items fatigue questionnaire reported as an aggregate score

Secondary outcomes

  1. Kings Sarcoidosis Questionnaire - General Health

    Time frame: From enrollment to end of study period at 5 months

    The KSQ General Health is a 10-item self-report survey reported as a single aggregate score which assesses quality of life in sarcoidosis.

  2. Patient Health Questionnaire - 8

    Time frame: From enrollment to end of study period at 5 months

    It is a self-reported measure of depressive symptom severity and consists of items consistent with criteria for DSM-based diagnosis. PHQ-8 scores range from 0 to 24. Each of the 8 items can be scored from 0 ("not at all") to 3 ("nearly every day"). Cut-points of 5, 10, 15, and 20 represent the thresholds for mild, moderate, moderately severe, and severe depression, respectively. The construct validity of the PHQ-8 has been demonstrated in a wide range of patient populations

  3. Generalized Anxiety Disorder-7

    Time frame: From enrollment to end of study period at 5 months

    7-item questionnaire that measures frequency of anxiety symptoms over the past 7 days. Response options are scored on a 4-point Likert scale ranging from "not at all" to "nearly every day." The summed score will be reported.

Other outcomes

  1. Five Facet of Mindfulness Scale (Short Form; FFMQ-15)

    Time frame: From enrollment to end of study period at 5 months

    The FFMQ is a measure of treatment fidelity. The FFMQ measures pre-post trait mindfulness and is assessed using 15 items that index the degree to which participants experience daily mindfulness, a central objective of MBSR treatment. Each item is rated on a 5-point scale from '1' = never or very rarely true to '5' = very often or always true. Reported as a single aggregate score

  2. Client Satisfaction Questionnaire (CSQ-8)

    Time frame: From enrollment to end of study period at 5 months

    The CSQ-8 is a validated questionnaire of patients satisfaction with mental health interventions. It involves summing response to 8 questions on a 4 point scale with scores ranging from 8 to 32.

Study contacts

Contact information is provided by the study sponsor or research team.

Logan J Harper, MD

CONTACT

[email protected]

216-444-0013

Tiana Powell

CONTACT

[email protected]

216-308-5111

Sponsors and collaborators

Lead sponsor

The Cleveland Clinic

Other

Collaborators

  • National Center for Advancing Translational Sciences (NCATS)
  • National Institute on Minority Health and Health Disparities (NIMHD)

Registry information

Acronym: SupportSarc

Important dates

Study start
2026
Primary completion
2028
Study completion
2028
First posted
Jul 20, 2025
Registry last updated
Apr 24, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.